References
- Warren JR, Marshall BJ. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulcer ulceration. Lanceti, 1273–1275 (1983).
- Wotherspoon AC, Doglioni C, Diss TC et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.Lancet342, 575–577 (1993).
- D’Elios MM, Appelmelk BJ, Amedei A et al. Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol. Med.7, 316–323 (2004).
- Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr. Eval. Carcinog. Risks Hum.61, 1–241 (1994).
- Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J. Clin. Invest.119, 2475–2487 (2009).
- D’Elios MM, Manghetti M, De Carli M et al. Th1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol.158, 962–967 (1997).
- D’Elios MM, Amedei A, Benagiano M et al.Helicobacter pylori, T cells and cytokines: the “dangerous liaisons”. FEMS Immunol. Med. Mic.44, 113–119 (2005).
- Fox JG, Beck P, Dangler CA et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat. Med.5, 536–542 (2000).
- D’Elios MM, Manghetti M, De Carli M et al. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur. J. Immunol.27, 1751–1755 (1997).
- Amedei A, Cappon A, Codolo G et al. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J. Clin. Invest.116, 1092–1101 (2006).
- Chatila TA, Li N, Garcia-Lloret et al. T-cell effector pathways in allergic diseases: transcriptional mechanisms and therapeutic targets. J. Allergy Clin. Immunol.121, 812–823 (2008).
- Robinson DS, Hamid Q, Ying S et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med.326, 295–304 (1992).
- Del Prete G, De Carli M, D’Elios MM et al. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur. J. Immunol.23, 1445–1449 (1993).
- Kon OM, Kay AB. T cells and chronic asthma. Int. Arch. Allergy Immunol.118, 2–4 (1999).
- Betts RJ, Kemeny DM. CD8+ T cells in asthma: friend or foe? Pharmacol. Ther.121, 155–168 (2009).
- Strachan DP. Hay fever, hygiene and household size. BMJ299, 1259–1260 (1989).
- Herz U, Lacy P, Renz H et al. The influence of infections on the development and severity of allergic disorders. Curr. Opin. Immunol.12, 632–640 (2000).
- Wohlleben G, Erb KJ. Immune stimulatory strategies for the prevention and treatment of asthma. Curr. Pharm. Des.12, 3281–3292 (2006).
- Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch. Intern. Med.167, 821–827 (2007).
- Hirota K, Kazaoka K, Niimoto I et al. Discovery of 8-hydroxyadenines as a novel type of interferon inducer. J. Med. Chem.45, 5419–5422 (2002).
- Trujillo-Vargas CM, Mayer KD, Bickert T et al. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses. Clin. Exp. Allergy35, 1003–1013 (2005).
- Codolo G, Mazzi P, Amedei A et al. The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma. Cell. Microbiol.10, 2355–2363 (2008).
- Malfertheiner P, Megraud F, O’Morain C et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut56, 772–781 (2007).